Cite
HARVARD Citation
Armuzzi, A. et al. (n.d.). DOP45 Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis. Journal of Crohn's and colitis. pp. i094-i095. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Armuzzi, A. et al. (n.d.). DOP45 Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis. Journal of Crohn's and colitis. pp. i094-i095. [Online].